NIH-funded research R01 grant

Mtb metabolites to spark MAIT cell protection in TB

Official title: M. tuberculosis metabolites to activate human mucosal-associated invariant T cells

Funded at Texas Biomedical Research Institute · NIH-11370177 · Data updated 2026-11-12

This grant looks at how tiny Mtb compounds can trigger MAIT cells to fight tuberculosis in people.

More Tuberculosis research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionTexas Biomedical Research Institute
NIH-funded
Lab location1 site (San Antonio, United States)
Project startJune 1, 2023
Project endMay 31, 2028
Funding year2026
Award (this year)$608,371
NIH project number5R01AI173245-04
Project IDNIH-11370177 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are people at risk for TB exposure or with early TB infection where MAIT cell responses could be harnessed.

Less likely to help

People without TB exposure or immune conditions affecting MAIT cell function may not benefit.

What this research studies

Tuberculosis remains a major global killer, and drug resistance makes it hard to treat. The project focuses on MAIT cells, a type of immune cell that can respond quickly to bacterial metabolites presented by a universal molecule. Researchers will study Mtb-derived metabolites and how they activate MAIT cells to produce an early immune response against TB. The work aims to identify new cellular targets and ways to boost protection in humans who are exposed to TB.

Why it matters

Potential benefit: If successful, the research could lead to new approaches that activate MAIT cells to improve protection against TB.

How similar studies have gone: Prior studies suggest MAIT cells can respond to bacterial metabolites and may contribute to protection, but more work is needed to translate this to TB.

Where this research is happening

  • Texas Biomedical Research Institute
    San Antonio, United States
    Active

Researchers

  • Principal investigator: Huang, Shouxiong — Texas Biomedical Research Institute
  • Study coordinator: Huang, Shouxiong

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.